Not Yet RecruitingNot Applicable

Echocardiographic Assessment of Pulmonary Hypertension in Obstructive Sleep Apnea

55 participantsStarted 2025-10-30

Plain-language summary

This study investigates the association between obstructive sleep apnea (OSA) and pulmonary hypertension (PH), focusing on the relationship between OSA severity and pulmonary arterial pressures in adult patients.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults aged 18-65 years Diagnosed with obstructive sleep apnea (OSA) by full-night polysomnography Apnea-Hypopnea Index (AHI) ≥ 5 events/hour Exclusion Criteria: Secondary pulmonary hypertension due to:Chronic pulmonary diseases, Left ventricular heart disease and Chronic thromboembolic disorders Use of pulmonary vasodilator therapy Long-term oxygen therapy (LTOT) Respiratory neuromuscular weakness Chest wall deformities End-organ failure (cardiac, renal, hepatic) Malignancy Obesity hypoventilation syndrome

What they're measuring

Mean Pulmonary Artery Pressure

Timeframe: baseline

Trial details

NCT IDNCT07184060

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04-30

View on ClinicalTrials.gov More Obstructive Sleep Apnea (OSA) trials